Journal of the American Heart Association, Volume 15, Issue 11 , June 2, 2026. BackgroundHow perivascular adipose tissue (PVAT) controls vascular remodeling and perivascular inflammation during pulmonary hypertension progresses remains unknown.MethodsWestern blotting, ELISA, immunohistochemistry, and immunofluorescence were used to measure proteins expression.
Sugen 5416 combined with hypoxia (SuHx) mouse models were established in C57BL/6 mice, and treated with CL‐316243. Adeno‐associated virus vector delivery was used to specifically delete nesfatin‐1 in adipocytes of lung in mice.
Transthoracic echocardiography was performed to evaluate the function of right ventricle. Assays for cell angiogenesis and adhesion were used to analyze endothelial cell function.
A noncontact transwell coculture model was used to evaluate the interaction between different types of cells.ResultsPVAT dysfunction participates in SuHx‐induced pulmonary vascular remodeling, PVAT exhibits features of white adipose tissue and the adipocytokine nesfatin‐1 is the key mediator. Browning of white adipose tissue via CL‐316243 treatment attenuates pulmonary hypertension phenotype in a SuHx–pulmonary hypertension mouse model.
Specific deletion of nesfatin‐1 in adipocytes of lung attenuates SuHx‐induced pulmonary vascular remodeling. Nesfatin‐1 secretion is induced by IL‐17/Th17 via PI3K/AKT/mTOR pathway.
Journal of the American Heart Association published a clinical update in Cardiology on 30 May 2026.
The item focuses on Adipokine Nesfatin‐1 Mediates Endothelial Dysfunction by Suppressing MEF2B/BMPR1A During Pulmonary Vascular Remodeling.
Review the original article for the full source wording and details.